PAVmed Inc. Series Z Warrant

Company Profile

PAVmed Inc. Series Z Warrant had its IPO on 2018-04-10 under the ticker symbol PAVMZ.

The company operates in the Other sector and Other industry. PAVmed Inc. Series Z Warrant has a staff strength of 0 employees.

Stock update

Shares of PAVmed Inc. Series Z Warrant opened at $0.16 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.16 - $0.27, and closed at $0.27.

This is a +42.11% increase from the previous day's closing price.

A total volume of 1,076 shares were traded at the close of the day’s session.

In the last one week, shares of PAVmed Inc. Series Z Warrant have increased by +128.81%.

PAVmed Inc. Series Z Warrant's Key Ratios

PAVmed Inc. Series Z Warrant has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months PAVmed Inc. Series Z Warrant’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures PAVmed Inc. Series Z Warrant's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, PAVmed Inc. Series Z Warrant’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q2, PAVmed Inc. Series Z Warrant’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

PAVmed Inc. Series Z Warrant’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into PAVmed Inc. Series Z Warrant’s profitability.

PAVmed Inc. Series Z Warrant stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

PAVmed Inc. Series Z Warrant stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$53.68 million

Total Liabilities

$50.79 million

Operating Cash Flow

$0

Capital Expenditure

$15000

Dividend Payout Ratio

0%

PAVmed Inc. Series Z Warrant ended 2024 with $53.68 million in total assets and $0 in total liabilities. Its intangible assets were valued at $53.68 million while shareholder equity stood at $-31512000.00.

PAVmed Inc. Series Z Warrant ended 2024 with $0 in deferred long-term liabilities, $50.79 million in other current liabilities, 109000.00 in common stock, $-260783000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $37.16 million and cash and short-term investments were $37.16 million. The company’s total short-term debt was $44,417,000 while long-term debt stood at $0.

PAVmed Inc. Series Z Warrant’s total current assets stands at $43.13 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $41000.00 compared to accounts payable of $1.16 million and inventory worth $243000.00.

In 2024, PAVmed Inc. Series Z Warrant's operating cash flow was $0 while its capital expenditure stood at $15000.

Comparatively, PAVmed Inc. Series Z Warrant paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.27

52-Week High

$0.7

52-Week Low

$0.05

Analyst Target Price

$

PAVmed Inc. Series Z Warrant stock is currently trading at $0.27 per share. It touched a 52-week high of $0.7 and a 52-week low of $0.7. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.13 and 200-day moving average was $0.24 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.